Surgery
Volume 146, Issue 6 , Pages 1063-1072 , December 2009

Routine pre-operative ultrasonography for papillary thyroid cancer: Effects on cervical recurrence

  • Christy L. Marshall, MD

      Affiliations

    • Department of Surgical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Jeffrey E. Lee, MD

      Affiliations

    • Department of Surgical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Yan Xing, MS, MD, PhD

      Affiliations

    • Department of Surgical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Nancy D. Perrier, MD

      Affiliations

    • Department of Surgical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Beth S. Edeiken, MD

      Affiliations

    • Department of Radiology, University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Douglas B. Evans, MD

      Affiliations

    • Department of Surgery, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Elizabeth G. Grubbs, MD

      Affiliations

    • Department of Surgical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX
    • Corresponding Author InformationReprint requests: Elizabeth G. Grubbs, MD, Assistant Professor, Department of Surgical Oncology, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030.

References 

  1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164–2167
  2. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794–804
  3. Samaan NA, Maheshwari YK, Nader S, Hill CS, Schultz PN, Haynie TP, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab. 1983;56:1131–1138
  4. Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447–1463
  5. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–953
  6. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879–885
  7. Simon D, Goretzki PE, Witte J, Roher HD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg. 1996;20:860–866discussion 66
  8. Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003;134:946–954discussion 54-5
  9. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–142
  10. The NCCN Clinical Practice Guidelines in Oncology™ Thyroid Carcinoma (V.1.2009). © 2009 National Comprehensive Cancer Network, Inc. Available at: NCCN.org. Accessed March 17, 2009. To view the most recent and complete version of the NCCN Guidelines, go online to NCCN.org.
  11. In:  Greene F,  Page D,  Fleming I,  Fritz A,  Balch C,  Haller D, et al. editor. AJCC cancer staging manual. 6th ed.. New York: Springer-Verlag; 2002;
  12. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16:1229–1242
  13. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A. Survival discriminants for differentiated thyroid cancer. Am J Surg. 1990;160:344–347
  14. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997;79:564–573
  15. Ghori FY, Gutterman-Litofsky DR, Jamal A, Yeung SC, Arem R, Sherman SI. Socioeconomic factors and the presentation, management, and outcome of patients with differentiated thyroid carcinoma. Thyroid. 2002;12:1009–1016

 Presented at the 30th Annual Meeting of the American Association of Endocrine Surgeons, Madison, Wisconsin, May 2–5, 2009.

PII: S0039-6060(09)00568-6

doi: 10.1016/j.surg.2009.09.027

Surgery
Volume 146, Issue 6 , Pages 1063-1072 , December 2009

Article Tools

* Image Usage & Resolution